GLP-1 Medication Users to Represent 35% of U.S. Food and Beverage Sales by 2030, New Circana Research Reveals
Chicago, Nov. 18, 2025 (GLOBE NEWSWIRE) — The rapid adoption of GLP-1 medications is fundamentally reshaping U.S. consumer spending habits and creating significant shifts in the retail sector, according to new research from Circana LLC. The findings show that households using these medications, which currently account for 23% of all U.S. households, are projected to […]